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Abstract Background: With an increasing volume of pri-
mary total shoulder arthroplasties (TSA), the number of
revision TSA cases is expected to increase as well. However,
the postoperative medical morbidity of revision TSA has not
been clearly described. Questions/Purposes: The purpose of
this study was to determine the rate of postoperative com-
plications following revision TSA, relative to primary TSA.
In addition, we sought to identify independent predictors of
complications, as well as to compare operative time and
postoperative length of stay between primary and revision
TSA. Methods: Patients who underwent primary/revision
TSA between 2005 and 2015 were identified in the Ameri-
can College of Surgeons National Surgical Quality Improve-
ment Program. Differences in complications, readmission
rates, operative time, length of stay, and predictors of com-
plications were evaluated using bivariate and multivariate
analyses. Results: A total of 10,371 primary TSA (95.4%)
and 496 revision TSA cases (4.6%) were identified. The
overall complication rate was 6.5% in primary and 10.7%
in revision TSA patients (p < 0.001). Multivariate analysis
identified an increased risk of any complication (odds ratio
1.73, p < 0.001), major complication (2.08, p = 0.001), and
wound infection (3.45, p = 0.001) in revision TSA patients,
relative to primary cases. Operative time was increased in
revision cases (mean ± standard deviation, 125 ± 62.5),
relative to primary (115 ± 47.7, p < 0.001). Age > 75, female
sex, history of diabetes or chronic obstructive pulmonary
disease, and American Society of Anesthesiologists classifi-
cation ≥ 3 were associated with increased risk of any com-
plication. Smoking history was the only significant predictor
of wound infection. Conclusion: Revision TSA, in compar-
ison to primary, poses an increased risk of postoperative
complications, particularly wound infections. A history of
smoking was an independent predictor of wound infections.
Keywords primary total shoulder arthroplasty.
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Introduction
The Agency for Healthcare Research and Quality predicts that
by 2030, joint replacement will become the most common
elective surgical procedure [1]. The most common of these
procedures are total hip arthroplasty (THA) and knee
arthroplasty (TKA), which exhibited 182 and 231% increases
in procedure volume between 2000 and 2010, respectively, in
the USA [2, 3]. In comparison, shoulder arthroplasty proce-
dure volume has increased by 534% between 2000 and 2010
in the USA [2, 4]. This growth in shoulder arthroplasty volume
may be due in part to the 2003 approval by the Food and Drug
Administration of the reverse shoulder arthroplasty procedure.
The reverse shoulder arthroplasty procedure has increased the
number of indications for arthroplasty, and is frequently used
to treat irreparable rotator cuff tears, cuff tear arthropathy, and
proximal humeral fractures, among other indications [5–7].
There is a reported revision rate of 17.4% (range 0–34%) at
9.4 years from anatomic primary TSA [8, 9], with the most
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common causes of failure including component loosening,
instability, and periprosthetic fractures reported in 6.3, 4.9,
and 1.8% of TSA patients, respectively [9]. Given this failure
rate and the increase in primary shoulder arthroplasty volume,
there will likely be a concomitant increase in the number of
revision shoulder arthroplasty cases in the future.
Previous studies have explored the outcomes of primary
TSA and have found postoperative complication rates be-
tween 3 and 14% [10–14]. However, TSA is an overall safe
procedure, with the incidence of mortality after primary TSA
between 0.09 and 0.4% within 30 days of the procedure [11,
12]. In contrast to primary TSA, there is a paucity of large
studies describing the short-term complication rates follow-
ing revision TSA. Several studies have assessed postopera-
tive complications and outcomes in revision TSA; however,
they either had small single-center cohorts, or lacked a
comparison to primary TSA patients. One study found a
postoperative complication rate of 29.7% at long-term fol-
low-up that included complications such as mechanical fail-
ure of the prosthesis and instability, in addition to medical
complications [15]. Another study using the National Hos-
pital Discharge Survey Database (NHDS) compared 1297
primary TSA to 184 revision TSA patients, and found that
revision TSA patients had a longer length of stay and an
increased myocardial infarction rate, but no difference in
other perioperative outcomes compared to primary TSA
patients [16].
Using a large dataset with prospectively collected 30-day
outcomes, the purpose of this study is to determine the
independent association between revision TSA and postop-
erative complications relative to primary TSA, including
both anatomic and reverse shoulder arthroplasty procedures.
Secondary objectives were to compare operative time and
postoperative length of stay between primary TSA and re-
vision TSA, as well as to identify patient risk factors for
postoperative complications.
Patients and Methods
We used the American College of Surgeons National Surgi-
cal Quality Improvement Program (ACS-NSQIP). This da-
tabase contains de-identified patient information from a
random sample of patients from diverse healthcare settings,
ranging from small community hospitals to large academic
medical centers. Data is prospectively collected by a trained
surgical clinical reviewer, and previous studies have demon-
strated a 98% interrater agreement rate between reviewers
[17]. Collected variables include demographics, comorbidi-
ties, and intraoperative and postoperative complications. As
of 2015, 274 unique variables were collected on each patient
from 603 participating institutions. In recent years, this
database has experienced tremendous growth in the number
of surgical encounters entered into the registry annually. For
instance, in 2005 there were approximately 150,000 unique
surgical encounters, and this has grown to over 880,000 in
2015. Complete methodology on patient inclusion and ex-
clusion criteria, data processing, and quality control mea-
sures are described elsewhere [18].
This study used ACS-NSQIP data from 2005 to 2015.
Primary TSA cases were selected by screening with Current
Procedural Terminology (CPT) codes for primary TSA (CPT
23472); hemiarthroplasty cases were not included in this
study. Revision TSA cases involving either the humeral or
the glenoid component (CPT 23473), and revision involving
both components (CPT 23474), were included in this study.
Primary and revision cases included both anatomic and
reverse procedures. Demographic information that was used
in this study included patient age and sex. Body mass index
was calculated using height and weight, and stratified ac-
cording to World Health Organization classifications. Co-
morbidities assessed included diabetes, chronic obstructive
pulmonary disease (COPD), hypertension, smoking history,
and American Society of Anesthesiologists (ASA) classifi-
cations, which is another measure of comorbidity burden. A
patient was considered to have a positive smoking history if
they smoked any cigarettes in the year prior to admission for
surgery. Emergency cases and those with contaminated
wound classifications were excluded from this study. Read-
mission data was only available from 2011 to 2015, and
therefore, the readmission analysis included only patients
from those years.
Postoperative complications that were analyzed included
death, pulmonary complications, deep vein thrombosis or
pulmonary embolism (DVT/PE), stroke or cerebrovascular
accident (CVA), sepsis, return to the operating room after the
initial procedure, wound infections (deep and superficial
surgical site infections), urinary tract infection (UTI), blood
transfusion, and readmission within 30 days of the proce-
dure. Pulmonary complications consisted of failure to wean
from the ventilator postoperatively, unplanned re-intubation,
and pneumonia. Major complications were defined as death,
pulmonary complications, DVT/PE, stroke/CVA, sepsis, or
return to the operating room. Minor complications were
defined as wound infections, UTI, or blood transfusion.
Baseline characteristics and postoperative complications
were compared between primary TSA and revision TSA.
Demographic information was compared using chi-squared
analysis. Postoperative complication data was compared
using bivariate and multivariate binary logistic regression
that controlled for baseline patient characteristics, including
age, sex, BMI, and comorbidities. Operative and postopera-
tive lengths of hospital stay were using Student’s t test.
Finally, multivariate logistic regression was applied to post-
operative complications and wound infections with baseline
patient characteristics as covariates to identify preoperative
characteristics that predicted adverse outcomes. Statistical
significance was set at p < 0.05, with Bonferroni corrections
to account for multiple group comparisons. Statistical anal-
ysis was performed with SPSS version 23 (IBM Corp.,
Armonk, NY).
Results
There were 10,371 primary TSA (95.4%) and 496 revision
TSA cases (4.6%) in this study. Patients in the revision TSA
group were younger (p < 0.001), were more likely to smoke
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(p < 0.001), and had a higher percentage of patients with an
ASA class of 3 or 4 (p = 0.002) compared to patients in the
primary TSA group (Table 1).
The risk of short-term adverse outcomes, including any
complication and wound infections, were higher for revision
TSA cases (p ≤ 0.001). Patients in the primary TSA group
had a 6.53% incidence of any complication, 2.31% of major
complication, and 4.82% of minor complication (Table 2).
The revision TSA group had a 10.7% incidence of any
complication, 4.64% of major complication, and 7.46% of
minor complications. On bivariate analysis, revision TSA
patients were found to have an increased risk of wound
infections (odds ratio [OR] 4.30, p < 0.001), major compli-
cations (OR 2.00, p = 0.001), any complication (OR 1.64,
p < 0.001), and returning to the operating room (OR 2.45,
p < 0.002). On multivariate analysis that controlled for
baseline characteristics, the revision group had an increased
risk of wound infections (OR 3.45, p = 0.001), major com-
plication (OR 2.08, p = 0.001), and any complication (OR
1.73, p < 0.001). No difference in readmission rate was
found between primary and revision TSA on bivariate or
multivariate analysis (OR 1.45, p = 0.12).
Revision TSA cases had a longer operative time than
primary cases (p < 0.001) These revision cases had a mean
operative time (± standard deviation) of 124.6 min (± 62.5),
which was significantly longer compared to primary TSA at
115 min (± 47.7, p < 0.001). No difference was found in
postoperative length of stay between primary TSA
(2.05 ± 3.01 days) and revision TSA (2.12 ± 1.70 days,
p = 0.766).
With multivariate logistic regression using any compli-
cation and wound infections as outcomes, age greater than
75 (OR 1.6, p < 0.001), female sex (OR 1.5, p < 0.001), a
history of diabetes (OR 1.4, p < 0.001) or COPD (OR 1.6,
p < 0.001), and ASA class 3 or 4 (OR 1.9, p < 0.001) were
found to significantly increase the risk of any complication
(Table 3). Only a history of smoking (OR 3.0, p < 0.001)
was found to increase the risk of wound infections following
adjustment for patient baseline covariates.
Discussion
The volume of revision TSA is expected to increase signif-
icantly in the coming years [9, 19]. Therefore, it is important
to better characterize postoperative outcomes in revision
TSA. Using a large, multicenter, prospectively collected
registry, this study attempted to characterize 30-day postop-
erative complications and predictive factors for these com-
plications and compare length of operative time and hospital
stay between primary and revision TSA patients. We found
an increase in wound infections, any complication, major
complication, and increased operative time, and identified
preoperative patient risk factors associated with postopera-
tive complications.
There are several limitations to this study. One of the
most important limitations is that ACS-NSQIP only contains
data until 30 days postoperatively, and therefore, we were
only able to assess short-term complications. Assessment of
complication rates between primary and revision TSA at
intermediate- and long-term time points is warranted in
future studies. Furthermore, ACS-NSQIP lacks data regard-
ing variables that are particularly important to TSA, includ-
ing functional outcomes, the timing of revision TSA relative
to primary TSA, the reason for the revision procedure, and
the inability to differentiate between anatomic and reverse
TSA. While we were unable to differentiate between these
two different shoulder arthroplasty procedures, previous
studies have found that both lead to improvements in func-
tional outcomes [20], and both have similar complication
rates, revision rates, and patient-reported outcomes at the 2-
year follow-up [21]. However, another study found that
Table 1 Comparison of patient and operative characteristics between primary and revision shoulder arthroplasty
Variable All patients Primary Revision p value
10,867 (100%) 10,371 (95.4%) 496 (4.6%)
Age < 0.001*
< 55 7.8% 7.5% 13.3%
55–65 21.8% 21.7% 24.4%
65–75 13.7% 38.8% 34.9%
> 75 31.8% 32.0% 27.3%
Female (%) 56.3% 56.3% 55.6% 0.766
Body mass index (kg/m2) 0.905
Non-obese (< 30) 50.4% 50.4% 51.5%
Obese I (30–34.9) 26.2% 26.2% 26.5%
Obese II (35–39.9) 13.5% 13.5% 12.7%
Obese III (> 40) 9.9% 10.0% 9.3%
Comorbidities
Diabetes 16.7% 16.6% 19.8% 0.062
Smoking 10.5% 10.2% 16.9% < 0.001*
COPD 6.2% 6.2% 7.7% 0.177
Hypertension 67.0% 67.1% 64.3% 0.194
ASA ≥ 3 52.6% 52.2% 59.3% 0.002*
Significant values are presented in bold
*Significance defined as p < 0.05
HSSJ (2018) 14:23–28 25
elderly patients older than 80 years had an increased rate of
perioperative complication and blood transfusion require-
ments in reverse relative to anatomic shoulder arthroplasty
[22]. This subset of patients only composed 12.3% of the
total patients undergoing primary or revision procedure in
our study. Furthermore, we were also unable to control for
variables such as surgeon training and the number of prima-
ry or revision TSA procedures that a surgeon or hospital
performs annually, which have been previously demonstrat-
ed to have an influence on postoperative outcomes [23], as
these were unavailable in the NSQIP.
Previous studies have also found a high rate of compli-
cations in revision TSA patients. In a 2013 case series of 37
patients who had undergone reverse TSA, Boileau et al.
found that 30% of the patients required re-intervention with
a minimum of 2 years follow-up, primarily due to joint
instability, humeral loosening or rotation, and infection
[24]. A 2016 retrospective case-control study by Antoni
et al. also assessed 37 patients who underwent revision
TSA. The authors found a high rate of perioperative com-
plications (54%), primarily due to joint instability and infec-
tion, that required re-intervention in 21.6% of patients [15].
Both of these studies had single-center cohorts that lacked
comparisons to a control group, and were also limited by
small sample size.
Additionally, a 2014 retrospective cohort study of
1297 primary TSA and 184 revision TSA patients using
the NHDS database found differences in baseline char-
acteristics between both groups, as well as differences in
postoperative course [25]. The authors found that revi-
sion TSA patients were younger, had a longer length of
stay compared to primary TSA patients (3.06 vs
2.46 days), and were more likely to develop a postop-
erative myocardial infarction. While they had the largest
revision TSA sample size to date, with a control group,
their analysis of outcomes was limited to only the initial
hospitalization, with no information on postdischarge
complications.
Table 2 Comparison of adverse outcomes after primary and revision total shoulder arthroplasty
Primary TSA Revision TSA Bivariate analysis Multivariate analysisa
n = 10,371 n = 496 OR p value OR p value
Any adverse complication 6.53% 10.69% 1.64 < 0.001* 1.73 < 0.001*
Major adverse complications 2.31% 4.64% 2.00 0.001* 2.08 0.001*
Death 0.17% 0.40% 2.32 0.244 2.56 0.211
Pulmonary complications 0.70% 0.40% 0.57 0.429 0.46 0.589
DVT/PE 0.33% 0.40% 1.23 0.775 1.29 0.729
Stroke/cerebrovascular accident 0.11% 0.20% 1.90 0.531 2.06 0.492
Sepsis 0.19% 0.81% 4.18 0.004 4.53 0.007
Return to operating room 1.07% 2.62% 2.45 0.001* 2.44 0.004
Minor adverse complications 4.82% 7.46% 1.55 0.008 1.59 0.010
Wound infection 0.33% 1.41% 4.30 < 0.001* 3.45 0.001*
Urinary tract infection 0.76% 1.41% 1.85 0.111 1.98 0.087
Blood transfusion 3.87% 5.24% 1.36 0.124 1.38 0.125
Readmission 2.87% 4.08% 1.42 0.120 1.45 0.118
Significant values are presented in bold
OR odds ratio, DVT/PE deep vein thrombosis/pulmonary embolism
*Significance defined as p < 0.0038 after correcting for multiple-group comparisons
aBinary logistic regression
Table 3 Independent risk factors for adverse outcomes by multivariate logistic regression
Revision TSA
Any adverse complication Wound infection
Variable OR (95% CI) p value OR (95% CI) p value
Age > 75 1.6 (1.4–1.8) < 0.001* 0.50 (0.0–1.5) 0.153
Female 1.5 (1.3–1.6) < 0.001* 0.96 (0.30–1.6) 0.906
Obese (BMI > 30 kg/m2) 0.81 (0.64–0.97) 0.012 1.4 (0.67–2.1) 0.372
Diabetes 1.4 (1.2–1.6) < 0.001* 1.3 (0.4–2.2) 0.598
Smoking 1.0 (0.78–1.2) 0.732 3.0 (2.3–3.8) 0.005*
COPD 1.6 (1.4–1.9) < 0.001* 1.0 (0.0–2.3) 0.910
Hypertension 1.0 (0.85–1.2) 0.921 0.84 (0.09–1.6) 0.644
ASA ≥ 3 1.9 (1.7–2.1) < 0.001* 1.0 (0.37–1.7) 0.983
Significant values are presented in bold
OR odds ratio, CI confidence interval, COPD chronic obstructive pulmonary disease, ASA American Society of Anesthesiologists
*Significance defined as p < 0.0063 after correcting for multiple-group comparisons
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In our study of 496 revision TSA and 10,371 primary TSA
patients, the risk of having any 30-day postoperative complica-
tion (10.7 vs 6.53%) and major complication (4.64 vs 2.31%)
was increased in revision compared to primary patients, respec-
tively. Studies of revision THA and TKA have also found high
postoperative complication rates as well (7.4 and 4.7%, respec-
tively) that are in line with the findings of this study [26].
Additionally, in our study, wound infections were significantly
more common in revision compared to primary cases (OR 3.45,
p = 0.001), which has also been demonstrated in revision THA
and TKA cases [27]. Our study identified a history of smoking
to be a significant independent risk factor for the development
of postoperative wound infections, which in previous studies
have also shown to increase the risk of postoperative healing
complications in both orthopedic and non-orthopedic surgeries
[27, 28]. In our study, the incidence of wound infections in
revision cases was found to be 1.41%, and is estimated to be 1.7
and 2.9% in revision TKA and THA, respectively, in other
studies [27]. Wound infections in revision shoulder cases, in
comparison to other types of revision joint procedures, may be
due the increased rate of Propionibacterium acne colonization
of the shoulder [29]. This anaerobic bacterium is most com-
monly found in the pilosebaceous follicles of the upper body,
such as the axilla, and a prior prosthetic implant significantly
increases the risk of infection [30].
Furthermore, this study showed that revision TSA cases
were longer than primary cases (p < 0.001), but did not
identify any differences in postoperative hospital length of
stay. A previous case series of 23 revision TSA patients
described operat ive length for this procedure at
113 ± 21 min (mean ± standard deviation); however, it
lacked a comparison to primary TSA [31]. Our study also
identified baseline patient characteristics that predict ad-
verse short-term postoperative outcomes, including age
greater than 65, female sex, history of diabetes or COPD,
and high ASA classification (3 or 4). Previous studies
looking at primary TSA patients found age and ASA clas-
sification as significant predictors of readmission and ad-
verse outcomes, which are in agreement with this study
[32]. Furthermore, our study showed that obesity (BMI
> 30 kg/m2) does not increase the risk of adverse
postoperative events, which has also been demonstrated in
other studies to not impact short-term outcomes in primary
TSA [25, 33, 34].
In conclusion, revision TSA cases are subject to in-
creases in adverse short-term postoperative events, in partic-
ular postoperative wound infections. Additionally, risk
factors including diabetes and smoking history were identi-
fied as increasing the risk of adverse postoperative events.
This information is useful to surgeons for preoperative risk
stratification, identifying risk factors that may place patients
at greater risk for complications, and for counseling patients
on surgical outcomes.
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